Quebec, Canada

Frank Courjal

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Geneohm Sciences, Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank Courjal. Retrieved from https://idiyas.com/inventor/frank-courjal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frank Courjal: Innovator in Detection Methods

Introduction

Frank Courjal is a notable inventor based in Québec, Canada. He has made significant contributions to the field of detection methods, particularly in the context of medical diagnostics. His work focuses on innovative approaches to detect and quantify specific pathogens.

Latest Patents

Frank Courjal holds 1 patent related to methods and compositions for the detection and/or quantification of pathogens from a sample. This patent includes embodiments that utilize nucleic acids capable of hybridizing to specific nucleic acid sequences, which are essential for identifying MRSA in a single assay.

Career Highlights

Frank Courjal is associated with Geneohm Sciences, Inc., a company dedicated to advancing diagnostic technologies. His role at the company has allowed him to contribute to the development of cutting-edge solutions in the healthcare sector.

Collaborations

Throughout his career, Frank has collaborated with talented individuals such as Véronique Jean and Mélanie Guillot. These partnerships have fostered innovation and enhanced the impact of their collective work in the field.

Conclusion

Frank Courjal's contributions to detection methods exemplify the importance of innovation in medical diagnostics. His work continues to influence the industry and improve healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…